Rabeprazole Joint Mosapride Treatment of Reflux Esophagitis Clinical Observation

Objective To observe rabeprazole joint mosapride treatment of reflux esophagitis clinical efficacy.Methods 46 patients with reflux esophagitis patients,randomly divided into treatment group of 23 patients and control group of 23 patients.Both groups were taking mosapride.In the observation group and then give rabeprazole.Results After 8 weeks,symptoms improved treatment group than the control group,clinical total effective rate was 95.6%,the two groups was significant difference(P0.05).Efficacy of endoscopic treatment group showed significantly better than the control group,total efficiency of 91.3%,the two groups was significant difference(P0.05).Conclusion Rabeprazole compared with ranitidine,more pronounced effect,can rapidly improve the symptoms and be effective drug for treatment of RE,should be worthy of promotion.